VRCA Market Cap History



Below is a table of the VRCA market cap history going back to 6/15/2018:

Date VRCA Market Cap
6/15/2018436.56M
8/7/2018369.00M
11/2/2018343.30M
3/4/2019325.45M
5/3/2019243.20M
8/5/2019276.98M
7/30/2019886.29M
11/1/2019369.87M
3/6/2020308.74M
5/4/2020266.66M
7/30/2020178.64M
11/5/2020192.70M
3/15/2021444.20M
5/3/2021340.15M
8/2/2021299.09M
11/3/2021354.45M
2/24/2022220.15M
5/2/2022181.63M
8/5/2022138.90M
11/2/202298.63M
3/1/2023317.24M
5/3/2023273.98M
8/1/2023235.98M
11/3/2023168.26M
2/23/2024219.73M

Also see: VRCA Shares Outstanding History
and VRCA YTD Return
VRCA Historical Market Cap:
-11.36% CAGR
VRCA Historical Market Cap: +-11.36% CAGR

Mouse over chart for data details
6/15/2018 ...2/23/2024
Verrica Pharmaceuticals is a dermatology therapeutics company developing medications for skin diseases requiring medical intervention. Co.'s product pipeline consists of: VP-102, which is a propriety drug-device combination that contains a good manufacturing practices-controlled formulation of cantharidin which is being developed for potential use in treating molluscum contagiosum, external genital warts and common warts; VP-315, which is an oncolytic peptide-based injectable therapy for the potential treatment of dermatology oncologic conditions, including basal cell carcinoma; and VP-103, which is a cantharidin based drug device combination for the potential treatment of plantar warts. We show 25 historical shares outstanding datapoints in our VRCA shares outstanding history coverage, used to compute VRCA market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing VRCA market cap history over the course of time is important for investors interested in comparing VRCA's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of VRCA versus a peer is one thing; comparing VRCA market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like VRCA can fluctuate over the course of history. With this page we aim to empower investors researching VRCA by allowing them to research the VRCA market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree VRCA Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Verrica Pharmaceuticals (VRCA) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

VRDN Market Cap History
VREX Market Cap History
VRML Market Cap History
VRPX Market Cap History
VRTX Market Cap History
VRX Market Cap History
VSAR Market Cap History
VSTM Market Cap History
VTGN Market Cap History
VTL Market Cap History
More Healthcare companies »

 

VRCA Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.